News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
14,809 Results
Type
Article (548)
Company Profile (3)
Press Release (14258)
Section
Business (8216)
Career Advice (11)
Deals (1311)
Drug Delivery (4)
Drug Development (1073)
Employer Resources (2)
FDA (155)
Job Trends (494)
News (9449)
Policy (343)
Tag
Academia (28)
Accelerated approval (1)
ADA (1)
Allergies (8)
Alliances (499)
ALS (8)
Alzheimer's disease (23)
Antibody-drug conjugate (ADC) (18)
Approvals (175)
Artificial intelligence (7)
ASCO (12)
Autoimmune disease (8)
Automation (1)
Bankruptcy (4)
Best Places to Work (427)
Biologics (1)
Biosimilars (8)
BioSpace Insights (1)
Bladder cancer (6)
Breast cancer (18)
Cancer (146)
Cardiovascular disease (13)
Career advice (12)
CAR-T (5)
CDC (1)
CDMO (1)
Cell therapy (12)
Cervical cancer (2)
Clinical research (1076)
Collaboration (38)
Compensation (18)
Complete response letters (1)
COVID-19 (44)
C-suite (19)
Cystic fibrosis (6)
Data (255)
Depression (4)
Dermatology (2)
Diabetes (13)
Diagnostics (173)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (4)
Drug pricing (5)
Drug shortages (1)
Earnings (7894)
Editorial (1)
Employer resources (2)
Events (854)
Executive appointments (17)
FDA (316)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (4)
Funding (56)
Gene editing (4)
Generative AI (1)
Gene therapy (14)
GLP-1 (32)
Government (45)
Guidances (100)
Healthcare (490)
Hematology (2)
HIV (1)
Huntington's disease (3)
IgA nephropathy (4)
Immunology and inflammation (7)
Immuno-oncology (1)
Indications (8)
Infectious disease (57)
Inflammatory bowel disease (2)
Inflation Reduction Act (1)
Influenza (3)
Intellectual property (7)
Interviews (2)
IPO (965)
IRA (1)
Job creations (97)
Job search strategy (8)
Labor market (1)
Layoffs (12)
Legal (54)
Liver cancer (4)
Longevity (1)
Lung cancer (21)
Lymphoma (14)
Manufacturing (24)
MASH (6)
Medical device (448)
Medtech (461)
Mergers & acquisitions (382)
Metabolic disorders (43)
mRNA (1)
Multiple sclerosis (4)
NASH (1)
Neurodegenerative disease (13)
Neuropsychiatric disorders (3)
Neuroscience (66)
NextGen: Class of 2026 (129)
Non-profit (56)
Now hiring (3)
Obesity (23)
Opinion (7)
Ovarian cancer (8)
Pain (3)
Pancreatic cancer (5)
Parkinson's disease (8)
Patents (5)
Patient recruitment (8)
Peanut (4)
People (398)
Pharmacy benefit managers (2)
Phase 1 (249)
Phase 2 (469)
Phase 3 (441)
Pipeline (765)
Policy (3)
Postmarket research (33)
Preclinical (86)
Prostate cancer (9)
Radiopharmaceuticals (13)
Rare diseases (29)
Real estate (68)
Recruiting (1)
Regulatory (346)
Reports (4)
Research institute (32)
Resumes & cover letters (4)
Rett syndrome (3)
RSV (6)
Schizophrenia (1)
Series A (10)
Series B (7)
Service/supplier (1)
Sickle cell disease (4)
Startups (49)
Stomach cancer (1)
Supply chain (3)
The Weekly (1)
Vaccines (32)
Venture capital (2)
Weight loss (18)
Women's health (9)
Date
Today (2)
Last 7 days (19)
Last 30 days (54)
Last 365 days (1148)
2026 (819)
2025 (1045)
2024 (1127)
2023 (1257)
2022 (1336)
2021 (1459)
2020 (1303)
2019 (921)
2018 (753)
2017 (667)
2016 (415)
2015 (558)
2014 (362)
2013 (251)
2012 (273)
2011 (283)
2010 (317)
Location
Africa (8)
Arizona (15)
Asia (779)
Australia (75)
California (480)
Canada (135)
China (47)
Colorado (30)
Connecticut (27)
Delaware (21)
Europe (2014)
Florida (58)
Georgia (34)
Illinois (48)
India (1)
Indiana (20)
Iowa (1)
Japan (11)
Kansas (3)
Kentucky (3)
Louisiana (3)
Maine (30)
Maryland (74)
Massachusetts (363)
Michigan (10)
Minnesota (37)
Missouri (3)
Montana (1)
Nevada (2)
New Hampshire (6)
New Jersey (157)
New York (247)
North Carolina (76)
Northern California (260)
Ohio (13)
Pennsylvania (126)
South America (23)
South Carolina (2)
Southern California (193)
Tennessee (11)
Texas (81)
United States (1965)
Utah (13)
Virginia (6)
Washington D.C. (1)
Washington State (30)
Wisconsin (5)
14,809 Results for "175".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Silence Therapeutics Announces Pricing of Upsized $175 Million Underwritten Public Offering
August 11, 2026
·
6 min read
Press Releases
Sagimet Biosciences Announces Pricing of $175.0 Million Underwritten Offering of Series A Common Stock
April 27, 2026
·
4 min read
Press Releases
Indivior Announces $175 Million Accelerated Share Repurchase
May 4, 2026
·
3 min read
Mergers & acquisitions
Ipsen makes up to $1.75B blood cancer bet with Kartos buyout
The star of Ipsen’s acquisition is an MDM2 blocker being proposed as an add-on therapy to ruxolitinib for myelofibrosis. The drug could be available to patients “as early as 2028,” according to Ipsen CEO David Loew.
June 29, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Biomerica Lands a $1.75 Million CDMO Master Services Agreement for IVD Diagnostic Development
May 28, 2026
·
4 min read
Press Releases
INOVIO Announces Pricing of $17.5 Million Public Offering
April 2, 2026
·
4 min read
Press Releases
Allogene Therapeutics Announces Proposed Public Offering of $175 Million of Common Stock
April 14, 2026
·
4 min read
Press Releases
Lysoway Therapeutics Awarded Grant from The Michael J. Fox Foundation to Advance TMEM175 Agonists for Parkinson’s Disease
June 1, 2026
·
3 min read
Press Releases
CytoDyn Closes $17.5 Million Financing to Fund Continued Development of Leronlimab
March 5, 2026
·
3 min read
Press Releases
ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing
February 1, 2026
·
7 min read
1 of 1,481
Next
